(ITB) U.S. Home Construction - Overview
Etf: Homebuilder, Supplier, Retailer, ETF
| Risk 5d forecast | |
|---|---|
| Volatility | 28.2% |
| Relative Tail Risk | -5.42% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.35 |
| Alpha | 0.42 |
| Character TTM | |
|---|---|
| Beta | 0.711 |
| Beta Downside | 0.493 |
| Drawdowns 3y | |
|---|---|
| Max DD | 33.35% |
| CAGR/Max DD | 0.62 |
Description: ITB U.S. Home Construction January 12, 2026
The iShares U.S. Home Construction ETF (BATS: ITB) tracks an index that captures the performance of U.S. home-building equities. The fund is required to hold at least 80 % of its net assets in the index’s constituent stocks and may allocate up to the remaining 20 % to futures, options, swaps, cash, or cash equivalents; it is classified as a non-diversified, consumer-cyclical ETF.
Key drivers to watch: (1) **Housing starts** – the U.S. Census Bureau reported 1.58 million new single-family starts in 2024 Q3, a 4 % YoY increase, which directly fuels revenue for ITB constituents. (2) **Builder confidence** – the NAHB/Wells Fargo Housing Market Index rose to 57 in October 2024, its highest level since 2022, suggesting stronger demand outlook. (3) **Mortgage rates** – the 30-year Treasury yield, a proxy for mortgage rates, has hovered around 4.8 % in recent weeks; lower rates historically correlate with higher home-builder margins, but any upward pressure could compress earnings.
Given the sensitivity of home-builder earnings to interest-rate cycles and inventory constraints, monitoring these macro variables can help assess ITB’s upside potential. For a deeper, data-driven breakdown of ITB’s exposure and risk metrics, you might find ValueRay’s analytics platform useful.
Altman Z''
Beneish M
| DSRI: none (Receivables none/none, Revenue 0.0/0.0) |
| GMI: 1.00 (fallback, negative margins) |
| AQI: none (AQ_t none / AQ_t-1 none) |
| SGI: none (Revenue 0.0 / 0.0) |
| TATA: none (NI 0.0 - CFO 0.0) / TA none) |
| Beneish M-Score: cannot calculate (missing components) |
What is the price of ITB shares?
Over the past week, the price has changed by -0.06%, over one month by +6.53%, over three months by +19.66% and over the past year by +11.97%.
Is ITB a buy, sell or hold?
What are the forecasts/targets for the ITB price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
ITB Fundamental Data Overview February 15, 2026
EBIT TTM = 0.0 USD
EBITDA TTM = 0.0 USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 3.01b USD (3.01b + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
EV/FCF = unknown (FCF TTM 0.0)
FCF Yield = 0.0% (FCF TTM 0.0 / Enterprise Value 3.01b)
FCF Margin = unknown (Revenue TTM is 0 or missing)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 3.01b / Total Assets none)
Interest Expense / Debt = unknown (Interest Expense 0.0 / Debt none)
Taxrate = 21.0% (US default 21%)
NOPAT = 0.0 (EBIT 0.0 * (1 - 21.00%))
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = unknown (Net Debt none / FCF TTM 0.0)
Total Stockholder Equity = 0.0 (from calculated bookValueOfEquity)
RoA = unknown (Net Income 0.0 / Total Assets none)
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity 0.0)
RoCE = unknown (EBIT 0.0 / Capital Employed )
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, EBIT 0.0)
WACC = 8.54% (E(3.01b)/V(3.01b) * Re(8.54%) + (debt-free company))
Discount Rate = 8.54% (= CAPM, Blume Beta Adj.)
Fair Price DCF = unknown (Cash Flow 0.0)